Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
NCT07338487Phase 1Recruiting
- Sponsor
- The Second Xiangya Hospital
- Start
- Apr 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial in cachexia comparing Nanocrystalline Megestrol Acetate Oral Suspension with Placebo Control (2 arms). Primary endpoint: Change in Body Mass Index at 8 weeks. Started Apr 2026; status: recruiting.
02
Drugs
megestrol
03
Conditions
cachexia
Beyond the preview
Go deeper on NCT07338487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07338487.